InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,631.22
(
0.28%
)
US TECH 100
19,876.40
(
0.42%
)
Dow Jones
40,211.72
(
0.53%
)
Brent Oil
84.34
(
-0.30%
)
Bitcoin
63,666.15
(
4.75%
)
Post# of 252605
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

seschm

Send PM Follow Ignore
Followers 1
Posts 326
Boards Moderated 0
Alias Born 12/11/2004

seschm

Re: None

Wednesday, 09/27/2017 9:39:41 AM

Wednesday, September 27, 2017 9:39:41 AM

Post# of 252605
MAVIRET™ (glecaprevir/pibrentasvir) Received Approval in Japan
https://finance.yahoo.com/news/enanta-announces-abbvie-maviret-glecaprevir-103000581.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up